Related Experiment Video

Updated: Jul 3, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.3K

RNA therapeutics in cancer treatment

Minh Nam Nguyen1, Van Thai Than2

  • 1Department of Biomedical Engineering, School of Medicine, Vietnam National University Ho Chi Minh City (VNU-HCM), Ho Chi Minh City, Vietnam; Research Center for Genetics and Reproductive Health (CGRH), School of Medicine, National University HCMC, Ho Chi Minh City, Vietnam.

Progress in Molecular Biology and Translational Science
|February 15, 2024
PubMed

Insights

RNA therapeutics offer targeted cancer treatment by interfering with disease-related genes or proteins. This approach shows promise for personalized medicine, minimizing side effects compared to traditional therapies.

Area of Science:

  • Biotechnology
  • Oncology
  • Molecular Biology

Background:

  • RNA therapeutics represent a novel class of drugs utilizing RNA molecules for disease treatment.
  • These therapies target specific genes or proteins implicated in disease progression.
  • Their application in cancer treatment offers a promising alternative to conventional methods due to enhanced specificity.

Purpose of the Study:

  • To explore the diverse types of RNA therapeutics employed in cancer treatment.
  • To elucidate the mechanisms of action for various RNA-based cancer therapies.
  • To discuss the potential applications, challenges, and future directions of RNA therapeutics in oncology.

Main Methods:

  • Review of current literature on RNA therapeutics for cancer.
  • Analysis of different RNA molecule types: small interfering RNA, microRNA, mRNA, and RNA aptamers.
  • Examination of mechanisms targeting cancer-specific genes and proteins.

Main Results:

  • RNA therapeutics demonstrate high specificity for cancer cells, sparing healthy tissues.
  • Various RNA types offer distinct mechanisms for precise intervention in cancer pathways.
  • Potential for personalized treatment strategies based on individual cancer profiles.

Conclusions:

  • RNA therapeutics hold significant potential for advancing cancer treatment paradigms.
  • Targeted delivery and mechanism-specific action are key advantages over traditional therapies.
  • Continued research and development are crucial for realizing the full clinical utility of RNA-based cancer drugs.
Keywords:
CancerNucleic acid therapeuticsRNA therapeuticsRNA-based drugsTreatment

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K